cyclophosphamide
20-328
Phase 1 small_molecule active
Quick answer
cyclophosphamide for Malignant Pleural Mesothelioma (MPM) is a Phase 1 program (small_molecule) at Atara Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atara Biotherapeutics
- Indication
- Malignant Pleural Mesothelioma (MPM)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active